Serine protease

0 marketed 2 in Phase 3

This page covers all Serine protease drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fibronectin and laminin (extracellular matrix proteins), Dietary proteins / extracellular proteolysis.

Targets

Fibronectin and laminin (extracellular matrix proteins) · Dietary proteins / extracellular proteolysis

Phase 3 pipeline (2)

Ocriplasmin 125µg · ThromboGenics · Ophthalmology
Ocriplasmin is a recombinant microplasmin that enzymatically cleaves fibronectin and laminin in the vitreous to dissolve vitreous-retinal adhesions.
CM-AT · Curemark · Neurology / Psychiatry
CM-AT is a serine protease that breaks down extracellular proteins to improve protein digestion and absorption in patients with autism spectrum disorder.